Page last updated: 2024-11-13
bam 12p
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
BAM 12P: Pro-Met-enkephalin precursor; isolated from bovine adrenal medulla; dodecapeptide Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 25077551 |
MeSH ID | M0087597 |
Synonyms (15)
Synonym |
---|
6,7-arg-8-val-9-gly-10-arg-11-pro-12-glu-met-enkephalin |
bam-12p |
75513-71-2 |
l-glutamic acid, n-(1-(n(2)-(n-(n-(n(2)-(n(2)-(n-(n-(n-(n-l-tyrosylglycyl)glycyl)-l-phenylalanyl)-l-methionyl)-l-arginyl)-l-arginyl)-l-valyl)glycyl)-l-arginyl)-l-prolyl)- |
methionine-enkephalin, arg(6,7)-val(8)-gly(9)-arg(10)-pro(11)-glu(12)- |
bam 12p |
enkephalin-met, arginyl(6,7)-valyl(8)-glycyl(9)-arginyl(10)-prolyl(11)-glu(12)- |
enkephalin-met, arg(6,7)-val(8)-gly(9)-arg(10)-pro(11)-glu(12)- |
met-enkephalin, arg(6,7)-val(8)-gly(9)-arg(10)-pro(11)-glu(12)- |
bam-12p (h-l-tyr-gly-gly-l-phe-l-met-l-arg-l-arg-l-val-gly-l-arg-l-pro-l-glu-oh) |
mfcd00076689 |
EX-A7440 |
bam12p |
(2s)-2-[[(2s)-1-[(2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)- 2-[[2-[[2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl] amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl] amino]-5-(diaminomethylideneamino)pentanoyl] |
AKOS040744571 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (14)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 11 (78.57) | 18.7374 |
1990's | 3 (21.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.48
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.48) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 16 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |